Infect Chemother.  2015 Sep;47(3):197-201. 10.3947/ic.2015.47.3.197.

Pertussis Accompanying Recent Mycoplasma Infection in a 10-Year-Old Girl

• Cheon MK
• Na H
• Han SB
• Kwon HJ
• Chun YH
• Kang JH

• KMID: 2068987
• DOI: http://doi.org/10.3947/ic.2015.47.3.197

Abstract

Recently, the incidence of pertussis has been increasing; however, reports on mixed infection of pertussis with other respiratory pathogens are rare in highly immunized populations. We report the case of a 10-year-old girl who presented with cough, post-tussive emesis, and fever. She was subsequently diagnosed with bronchopneumonia. Although she had received five doses of diphtheria-tetanus-acellular pertussis vaccine, polymerase chain reaction of her nasopharyngeal aspirate confirmed Bordetella pertussis infection. In addition, serologic testing for Mycoplasma pneumoniae was also positive. The patient was treated with roxithromycin without any complications. This is the first report of mixed B. pertussis and M. pneumoniae infection in Korea. To avoid under-diagnosis, pertussis should be considered in patients with chronic cough even when other respiratory pathogens have been documented.

Keyword

Bordetella pertussis; Mycoplasma pneumoniae; Coinfection; Child

MeSH Terms

Bordetella pertussis
Bronchopneumonia
Child*
Coinfection
Cough
Female*
Fever
Humans
Incidence
Korea
Mycoplasma Infections*
Mycoplasma pneumoniae
Mycoplasma*
Pertussis Vaccine
Pneumonia
Pneumonia, Mycoplasma
Polymerase Chain Reaction
Roxithromycin
Serologic Tests
Vomiting
Whooping Cough*
Pertussis Vaccine
Roxithromycin

Figure

• 

  Figure 1 Chest X-rays showed (A) pneumonic infiltrations on admission, and (B) improved findings on the seventh day of hospitalization.

Reference

1. Güriş D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, Wharton M, Livengood JR. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999; 28:1230–1237.

2. Park B, Lee YK, Cho LY, Go UY, Yang JJ, Ma SH, Choi BY, Lee MS, Lee JS, Choi EH, Lee HJ, Park SK. Estimation of nationwide vaccination coverage and comparison of interview and telephone survey methodology for estimating vaccination status. J Korean Med Sci. 2011; 26:711–719.

3. Hong JY. Update on pertussis and pertussis immunization. Korean J Pediatr. 2010; 53:629–633.

4. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005; 24:5 Suppl. S25–S34.

5. Versteegh FG, Mooi-Kokenberg EA, Schellekens JF, Roord JJ. Bordetella pertussis and mixed infections. Minerva Pediatr. 2006; 58:131–137.

6. Versteegh FG, Weverling GJ, Peeters MF, Wilbrink B, Veenstra-van Schie MT, van Leeuwen-Gerritsen JM, Mooi-Kokenberg EA, Schellekens JF, Roord JJ. Community-acquired pathogens associated with prolonged coughing in children: a prospective cohort study. Clin Microbiol Infect. 2005; 11:801–807.

7. Jackson LA, Cherry JD, Wang SP, Grayston JT. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis. 2000; 31:3–6.

8. Chong YP, Jung KS, Lee KH, Kim MN, Moon SM, Park S, Hur J, Kim DM, Jeon MH, Woo JH. The bacterial etiology of community-acquired pneumonia in Korea: a nationwide prospective multicenter study. Infect Chemother. 2010; 42:397–403.

9. European Centre for Disease Prevention and Control. Guidance and protocol for the use of real-time PCR in laboratory diagnosis of human infection with Bordetella pertussis or Bordetella parapertussis. Stockholm: ECDC;2012.

10. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis. 2000; 182:1409–1416.

11. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005; 24:6 Suppl. S104–S108.

12. Korea Centers for Disease Control and Prevention. Increasing incidence of pertussis in Korea, 2009. Public Health Wkly Rep. 2009; 2:709.

13. Cherry JD. Mycoplasma and Ureaplasma infections. In : Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Feigin and Cherry's textbook of pediatric infectious diseases. 6th ed. Philadelphia, Pa: Saunders Elsevier;2009. p. 2685–2714.

14. Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008; 32:956–973.

15. Cunha BA. The clinical diagnosis of Mycoplasma pneumoniae: the diagnostic importance of highly elevated serum cold agglutinins. Eur J Clin Microbiol Infect Dis. 2008; 27:1017–1019.

16. Chaudhry R, Sharma S, Javed S, Passi K, Dey AB, Malhotra P. Molecular detection of Mycoplasma pneumoniae by quantitative real-time PCR in patients with community acquired pneumonia. Indian J Med Res. 2013; 138:244–251.

17. Mink CM, Cherry JD, Christenson P, Lewis K, Pineda E, Shlian D, Dawson JA, Blumberg DA. A search for Bordetella pertussis infection in university students. Clin Infect Dis. 1992; 14:464–471.

18. Mertsola J, Ruuskanen O, Eerola E, Viljanen MK. Intrafamilial spread of pertussis. J Pediatr. 1983; 103:359–363.

19. Baraff LJ, Wilkins J, Wehrle PF. The role of antibiotics, immunizations, and adenoviruses in pertussis. Pediatrics. 1978; 61:224–230.

20. Nelson KE, Gavitt F, Batt MD, Kallick CA, Reddi KT, Levin S. The role of adenoviruses in the pertussis syndrome. J Pediatr. 1975; 86:335–341.